A pair of engineers at Hohai University in Nanjing, China, has lost their 2012 paper in the Journal of Computational and Applied Mathematics. The reason: The article, “Study of the New Leon model for concrete failure,” wasn’t theirs to publish.
According to the retraction notice (which is dated September 2013 but has already appeared in ScienceDirect): Continue reading Retraction for water researchers who ripped off dissertation
Laurence Cole, an obstetrics researcher at the University of New Mexico, made an appearance on this blog in November 2011 after the American Journal of Obstetrics & Gynecology published a remarkably heavy-handed retraction of one of his papers.
Shortly after, we learned that the retraction was preceded by a strongly-worded letter from an attorney representing a company that had been miffed by the content of Cole’s article (the issue involved the effectiveness of commercially-available pregnancy tests, and Cole’s failure to adequately disclose a past relationship with the aggrieved company’s competitor). That letter read, in part: Continue reading New Mexico obstetrics researcher violated research subject protocols: Retraction notice
We’ve been following the case of Kenji Okajima, a professor at Nagoya City University in Japan who was suspended for six months following an investigation into work in his lab. Bits of the story — including at least one other university investigation, and scrutiny of Okajima’s colleagues, one of whom was fired — have been dribbling out for almost two years since a retraction notice in the Journal of Neuroscience.
In all, it looks as Nagoya found evidence of misconduct in 19 papers. The Journal of Neuroscience retraction appeared in 2011, and another showed up in the Journal of Immunology last year. Now there are three more: One in Translational Research and two in Blood.
Here’s the notice from Translational Research: Continue reading Kenji Okajima retraction count grows to five
Earlier this month, we brought you the story of a paper in a journal about business ethics being retracted for — wait for it — plagiarism. The paper that seemed to be the one in question — see the post for why that was a bit unclear — was by Benjamin A. Neil, a professor at Towson University in Maryland.
Today, the Baltimore Sun reports that Neil is under investigation by Towson for more alleged plagiarism, and has “resigned his post as the head of the city school system’s ethics panel.” From the Sun: Continue reading Is defining plagiarism “like catching smoke in a butterfly net?” Towson professor under investigation
A group of researchers from Shangdong, China, has retracted their 2011 paper in the Journal of Molecular Medicine on the heart-protective properties of a substance in ginseng because the article contained dodgy figures.
The article, “Ginsenoside-Rg1 enhances angiogenesis and ameliorates ventricular remodeling in a rat model of myocardial infarction,” purported to show that ginsenoside: Continue reading Image problems lead to demise of paper on ginseng for heart attack
Joseph Hoffman, an animal behavior researcher at the University of Bielefeld in Germany says he got a “kind of odd” feeling as he read a recent paper on the transcriptome of the spotted seal. Let’s just call it deja vu.
The article, “Characterization of the spotted seal Phoca largha transcriptome using Illumina paired-end sequencing and development of SSR markers,” which appeared in Comparative Biochemistry and Physiology Part D: Genomics and Proteomics:
Continue reading Seals of disapproval, as pinniped paper gets yanked for plagiarism
It’s Diederik Stapel’s golden retraction: Number 50.
The lucky notice appears in Social Psychology: Continue reading Diederik Stapel retraction count hits 50
The Surgeon has retracted a 2012 article by a group from the U.K. who took text from a previously published article. So, you say? Nu?
Well, we found — through relatively little effort — that the plagiarizees were themselves, shall we say, liberal in their use of material from other sources.
The retracted article was titled “Bone graft substitutes: What are the options?,” and it appeared in August 2012. One of the options, we guess, was to steal text.
According to the retraction notice: Continue reading Post 982 — in which we find plagiarized bone graft paper that grafted from other papers
Pharmaceutical Biology has retracted a 2012 paper by a group of liver researchers from China after the discovery of an error that evidently invalidated the results in the paper.
The article, “Antifibrotic effects of protocatechuic aldehyde on experimental liver fibrosis,” purported to show that
protocatechuic aldehyde, the major degradation of phenolic acids … has potentially conferring antifibrogenic effects.
A six year-old review on bird flu that failed to credit some content from another six year-old review of bird flu is now stamped with an Expression of Concern.
Here’s the notice, from Influenza and Other Respiratory Viruses: Continue reading Flu paper duplication earns Expression of Concern